Clinical Trials

The James Cancer Center Columbus, OH

open for enrollment

Sorafenib w/ or w/o Everolimus in Pts w/ Radioactive Iodine Refractory Hürthle Cell Thyroid Cancer

Protocol: ALLIANCE-A091302

Full Title

Randomized Phase II Study of Sorafenib with or without Everolimus in Patients with Radioactive Iodine Refractory Hürthle Cell Thyroid Cancer

Endocrine Cancers Thyroid Cancer